Jay Tibbitts

Medicine · Health Sciences

25h-index4.2kcitations122works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(71), Monoclonal and Polyclonal Antibodies Research(56), Radiopharmaceutical Chemistry and Applications(17), CAR-T cell therapy research(11), Click Chemistry and Applications(10)

Publications122 total

Author response: R-Spondin Mimetic, SZN-043, Induced Proliferation and Expression of Wnt Target Genes, Two Impaired Features in Human Alcohol-Associated Liver Disease
2025Open Access
R-Spondin Mimetic, SZN-043, Induced Proliferation and Expression of Wnt Target Genes, Two Impaired Features in Human Alcohol-Associated Liver Disease
2025Open Access
R-Spondin Mimetic, SZN-043, Induced Proliferation and Expression of Wnt Target Genes, Two Impaired Features in Human Alcohol-Associated Liver Disease
2025Open Access
R-Spondin Mimetic, SZN-043, Induced Proliferation and Wnt Activity, Two Features Deficient in Human Alcohol-Associated Liver Disease
2025Open Access
R-Spondin Mimetic, SZN-043, Induced Proliferation and Expression of Wnt Target Genes, Two Impaired Features in Human Alcohol-Associated Liver Disease
2024Open Access
SAT-261 Preliminary results of a phase I study of SZN-043, a novel RSpondin mimetic, in healthy volunteers and subjects with liver cirrhosis
Journal of Hepatology·2024
Sa1213 SZN-1326, A WNT MIMETIC, DECREASED INTESTINAL FIBROSIS IN A DEXTRAN SULFATE SODIUM (DSS)-INDUCED CHRONIC COLITIS MOUSE MODEL
Gastroenterology·2023
Supplementary Figure Legend 1 from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
Supplementary Figure 1 from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
Data from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
Data from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
2023Open Access
Data from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
2023Open Access
Supplementary Figure Legend 1 from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
Supplementary Table 1-2 from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
2023Open Access
Supplementary Figure 1 from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
Data from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
Supplementary Table 1-2 from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
2023Open Access
SupplementaryTable 1 from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
SupplementaryTable 1 from The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
2023Open Access
Supplementary Figure 1 from Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Sandhya Girish(11), Ben‐Quan Shen(8), Ola M. Saad(7), Mark X. Sliwkowski(7), Douglas D. Leipold(7), Elaine Mai(6), Leslie A. Khawli(6), Shanu Modi(6), Surinder Kaur(5), Daniela Bumbaca(5), S. G. Lutzker(5), Scott N. Holden(4), Gail D. Lewis Phillips(4), Paul J. Fielder(4), M. Beeram(4), IE Krop(4), Frank R. Brennan(4), John R. Fike(4), Stephen B. Kahl(4), Andreas Baumann(4)